Stephen Young
CFO
Replay available
EKF Diagnostics Holdings plc (LSE: EKF) Q4 2024 earnings conference call, held 2025-03-25. Replay captured from the company's public earnings webcast.

CFO
Executive Chair
CEO
Watch the replay and follow the connected company analysis, news, and investor updates for Ekf Diagnostics Holdings Plc.
WEBVTT 00:00:00.031 -- 00:00:03.941 Ladies and gentlemen, and welcome to the EKF Diagnostic Holdings Premier Results investor 00:00:03.941 -- 00:00:07.229 presentation. Throughout today's recorded presentation, investors will be in listen-only 00:00:07.229 -- 00:00:11.540 mode. Questions are encouraged and can be submitted at any time using the Q&A tab situated 00:00:11.540 -- 00:00:14.567 on the right-hand corner of your screen. Please simply type in your questions at any 00:00:14.567 -- 00:00:18.617 time and press send. The company may not be in a position to answer every question received 00:00:18.617 -- 00:00:21.560 during the meeting itself. However, the company can review all questions submitted today, 00:00:21.560 -- 00:00:24.444 and we'll publish those responses where it's appropriate to do so. 00:00:24.444 -- 00:00:27.988 Before we begin, we'd like to submit the following poll, and I'd now like to hand over 00:00:27.988 -- 00:00:31.752 to Executive Chair, Julian Baines. Good afternoon. 00:00:31.752 -- 00:00:37.980 Good afternoon, everyone. Thank you very much for joining the EKF Diagnostics final results 00:00:37.980 -- 00:00:43.186 presentation. I'm joined here today by our new CEO, Gavin Jones, 00:00:43.186 -- 00:00:48.658 and by our CFO, Stephen Young. and I will start the presentation straight 00:00:48.658 -- 00:00:50.939 away. So 00:00:51.088 -- 00:00:56.192 in terms of the business, I think that the business has performed really 00:00:56.192 -- 00:00:58.975 well against what 00:00:58.975 -- 00:01:01.177 the board tasked us to do over the last year. 00:01:01.177 -- 00:01:06.544 We've had revenues of £50.2 million and that reflects the removal 00:01:06.544 -- 00:01:10.809 of any legacy products we had in our portfolio, which we've done very successfully....